Bergeson & Campbell, P.C. Contributes Chapter to Biointeractions of Nanomaterials

Bergeson & Campbell, P.C., is pleased to announce that Managing Partner Lynn L. Bergeson and the late Michael F. Cole prepared a chapter in a new book, Biointeractions of Nanomaterials, which covers a wide range of issues associated with the safety of nanomaterials in biological systems. The book, published on July 29, 2014, by CRC Press, addresses issues related to the toxicity and safety of nanomaterials and nanosystems, and covers a range of interactions in biological systems, specifically focusing on the tools and methods used for evaluation, including in vivo and in vitro techniques.

Ms. Bergeson and Mr. Cole’s chapter, The Regulatory Implications of Nanotechnology, examines the effect regulation is having or may have on the commercialization of nanomaterials in the pharmaceutical and medical fields in the U.S. and abroad. The chapter discusses the types of regulatory schemes being enacted or considered, and whether different governance systems are likely to have differing effects on nanomedicine, including the effect on competition among companies and countries.